| Dr Min Zhou, MD | |
|
2600 6th St Sw, Medical Education, Canton, OH 44710-1702 | |
| (330) 363-4899 | |
| (330) 580-5513 |
| Full Name | Dr Min Zhou |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 37 Years |
| Location | 2600 6th St Sw, Canton, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780898163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 35.093387 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aultman Hospital | Canton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohio Physician Professional Corporation | 2668406059 | 105 |
News Archive
A new study published in the journal BMC Public Health reports that children who were physically or sexually abused, neglected or otherwise treated badly, are at higher risk of showing delinquent behavior or offending the law, as they grow into their teens and later into young adults. The childhood experience of maltreatment and violence is a powerful factor in predisposing the growing youth to behave badly.
Chrissie Fletcher joined Pharma IQ to talk about Health Technology Assessment. In this comprehensive podcast, she discussed how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future.
Family members didn't give CPR for cardiac arrests as often as passers-by or friends in a Japanese study presented at the American Heart Association's Scientific Sessions 2012.
Osaka Researchers, in partnership with other Japanese and U.S. scientists, report a new gene target, KPNB1, for treatment against epithelial ovarian cancer (EOC).
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of Richland County, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639119027 PECOS PAC ID: 4284538430 Enrollment ID: O20031120000557 |
News Archive
A new study published in the journal BMC Public Health reports that children who were physically or sexually abused, neglected or otherwise treated badly, are at higher risk of showing delinquent behavior or offending the law, as they grow into their teens and later into young adults. The childhood experience of maltreatment and violence is a powerful factor in predisposing the growing youth to behave badly.
Chrissie Fletcher joined Pharma IQ to talk about Health Technology Assessment. In this comprehensive podcast, she discussed how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future.
Family members didn't give CPR for cardiac arrests as often as passers-by or friends in a Japanese study presented at the American Heart Association's Scientific Sessions 2012.
Osaka Researchers, in partnership with other Japanese and U.S. scientists, report a new gene target, KPNB1, for treatment against epithelial ovarian cancer (EOC).
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
| Entity Name | Inpatient Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093756314 PECOS PAC ID: 6406753045 Enrollment ID: O20031212000790 |
News Archive
A new study published in the journal BMC Public Health reports that children who were physically or sexually abused, neglected or otherwise treated badly, are at higher risk of showing delinquent behavior or offending the law, as they grow into their teens and later into young adults. The childhood experience of maltreatment and violence is a powerful factor in predisposing the growing youth to behave badly.
Chrissie Fletcher joined Pharma IQ to talk about Health Technology Assessment. In this comprehensive podcast, she discussed how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future.
Family members didn't give CPR for cardiac arrests as often as passers-by or friends in a Japanese study presented at the American Heart Association's Scientific Sessions 2012.
Osaka Researchers, in partnership with other Japanese and U.S. scientists, report a new gene target, KPNB1, for treatment against epithelial ovarian cancer (EOC).
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
| Entity Name | Ohio Physician Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417016973 PECOS PAC ID: 2668406059 Enrollment ID: O20050925000062 |
News Archive
A new study published in the journal BMC Public Health reports that children who were physically or sexually abused, neglected or otherwise treated badly, are at higher risk of showing delinquent behavior or offending the law, as they grow into their teens and later into young adults. The childhood experience of maltreatment and violence is a powerful factor in predisposing the growing youth to behave badly.
Chrissie Fletcher joined Pharma IQ to talk about Health Technology Assessment. In this comprehensive podcast, she discussed how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future.
Family members didn't give CPR for cardiac arrests as often as passers-by or friends in a Japanese study presented at the American Heart Association's Scientific Sessions 2012.
Osaka Researchers, in partnership with other Japanese and U.S. scientists, report a new gene target, KPNB1, for treatment against epithelial ovarian cancer (EOC).
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of Ohio, Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043572290 PECOS PAC ID: 3779749197 Enrollment ID: O20120730000162 |
News Archive
A new study published in the journal BMC Public Health reports that children who were physically or sexually abused, neglected or otherwise treated badly, are at higher risk of showing delinquent behavior or offending the law, as they grow into their teens and later into young adults. The childhood experience of maltreatment and violence is a powerful factor in predisposing the growing youth to behave badly.
Chrissie Fletcher joined Pharma IQ to talk about Health Technology Assessment. In this comprehensive podcast, she discussed how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future.
Family members didn't give CPR for cardiac arrests as often as passers-by or friends in a Japanese study presented at the American Heart Association's Scientific Sessions 2012.
Osaka Researchers, in partnership with other Japanese and U.S. scientists, report a new gene target, KPNB1, for treatment against epithelial ovarian cancer (EOC).
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of Ohio - Akron, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780229419 PECOS PAC ID: 0042647638 Enrollment ID: O20200220000606 |
News Archive
A new study published in the journal BMC Public Health reports that children who were physically or sexually abused, neglected or otherwise treated badly, are at higher risk of showing delinquent behavior or offending the law, as they grow into their teens and later into young adults. The childhood experience of maltreatment and violence is a powerful factor in predisposing the growing youth to behave badly.
Chrissie Fletcher joined Pharma IQ to talk about Health Technology Assessment. In this comprehensive podcast, she discussed how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future.
Family members didn't give CPR for cardiac arrests as often as passers-by or friends in a Japanese study presented at the American Heart Association's Scientific Sessions 2012.
Osaka Researchers, in partnership with other Japanese and U.S. scientists, report a new gene target, KPNB1, for treatment against epithelial ovarian cancer (EOC).
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Min Zhou, MD 2600 6th St Sw, Medical Education, Canton, OH 44710-1702 Ph: (330) 363-4899 | Dr Min Zhou, MD 2600 6th St Sw, Medical Education, Canton, OH 44710-1702 Ph: (330) 363-4899 |
News Archive
A new study published in the journal BMC Public Health reports that children who were physically or sexually abused, neglected or otherwise treated badly, are at higher risk of showing delinquent behavior or offending the law, as they grow into their teens and later into young adults. The childhood experience of maltreatment and violence is a powerful factor in predisposing the growing youth to behave badly.
Chrissie Fletcher joined Pharma IQ to talk about Health Technology Assessment. In this comprehensive podcast, she discussed how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future.
Family members didn't give CPR for cardiac arrests as often as passers-by or friends in a Japanese study presented at the American Heart Association's Scientific Sessions 2012.
Osaka Researchers, in partnership with other Japanese and U.S. scientists, report a new gene target, KPNB1, for treatment against epithelial ovarian cancer (EOC).
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
Dr. Rimon Daoud, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1320 Mercy Dr Nw, Canton, OH 44708 Phone: 330-489-1111 |